Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery KLK7
Path
Created with Sketch.
Go to KLK7 Normal Tissue Gallery
Go back to Product Page
Anal canal- Squamous cell carcinoma with strong KLK7 immunostaining in a zone of keratinization.
Anal canal- Squamous cell carcinoma with strong KLK7 immunostaining in a zone of keratinization.
Breast- Invasive breast cancer of no special type (NST) showing a distinct KLK7 immunostaining of tumor cells.
Breast- Invasive breast cancer of no special type (NST) showing a distinct KLK7 immunostaining of tumor cells.
Breast- KLK7 negative invasive lobular breast cancer.
Breast- KLK7 negative invasive lobular breast cancer.
Colon- Colorectal adenocarcinoma exhibiting a weak to moderate KLK7 staining in a fraction of tumor cells.
Colon- Colorectal adenocarcinoma exhibiting a weak to moderate KLK7 staining in a fraction of tumor cells.
Colon- KLK7 negative colorectal adenocarcinoma
Colon- KLK7 negative colorectal adenocarcinoma
Esophagus- Adenocarcinoma with KLK7 immunostaining of variable intensity in most tumor cells.
Esophagus- Adenocarcinoma with KLK7 immunostaining of variable intensity in most tumor cells.
Esophagus- Squamous cell carcinoma with KLK7 immunostaining in a zone of keratinization.
Esophagus- Squamous cell carcinoma with KLK7 immunostaining in a zone of keratinization.
Kidney- KLK7 negative clear cell carcinoma
Kidney- KLK7 negative clear cell carcinoma
Liver- KLK7 negative hepatocellular carcinoma.
Liver- KLK7 negative hepatocellular carcinoma.
Lung- KLK7 negative malignant mesothelioma (epitheloid).
Lung- KLK7 negative malignant mesothelioma (epitheloid).
Lung- KLK7 negative small cell carcinoma.
Lung- KLK7 negative small cell carcinoma.
Lung- KLK7 negative squamous cell carcinoma.
Lung- KLK7 negative squamous cell carcinoma.
Lymph node- KLK7 negative Hodgkin’s lymphoma.
Lymph node- KLK7 negative Hodgkin’s lymphoma.
Oral cavity- Squamous cell carcinoma with strong KLK7 immunostaining in areas of keratinization.
Oral cavity- Squamous cell carcinoma with strong KLK7 immunostaining in areas of keratinization.
Ovary- KLK7 negative endometroid carcinoma.
Ovary- KLK7 negative endometroid carcinoma.
Ovary- Serous high-grade carcinoma with strong KLK7 immunostaining of tumor cells.
Ovary- Serous high-grade carcinoma with strong KLK7 immunostaining of tumor cells.
Pancreas- Adenocarcinoma of the papilla Vaterii with KLK7 immunostaining of most tumor cells.
Pancreas- Adenocarcinoma of the papilla Vaterii with KLK7 immunostaining of most tumor cells.
Pancreas- Ductal adenocarcinoma showing a faint KLK7 staining of tumor cells.
Pancreas- Ductal adenocarcinoma showing a faint KLK7 staining of tumor cells.
Pancreas- KLK7 negative neuroendocrine tumor.
Pancreas- KLK7 negative neuroendocrine tumor.
Penis- Squamous cell carcinoma with strong KLK7 staining in an area depicting keratinization.
Penis- Squamous cell carcinoma with strong KLK7 staining in an area depicting keratinization.
Pharynx- Squamous cell carcinoma with strong KLK7 immunostaining of most tumor cells.
Pharynx- Squamous cell carcinoma with strong KLK7 immunostaining of most tumor cells.
Prostate- KLK7 negative adenocarcinoma (Gleason 3+3=6).
Prostate- KLK7 negative adenocarcinoma (Gleason 3+3=6).
Salivary gland- Warthin tumor with moderate to strong KLK7 immunostaining of most epithelial tumor cells.
Salivary gland- Warthin tumor with moderate to strong KLK7 immunostaining of most epithelial tumor cells.
Skin- Keratinizing squamous cell carcinoma with strong KLK7 immunostaining of most tumor cells.
Skin- Keratinizing squamous cell carcinoma with strong KLK7 immunostaining of most tumor cells.
Skin- KLK7 negative basal cell carcinoma.
Skin- KLK7 negative basal cell carcinoma.
Skin- KLK7 negative Merkel cell carcinoma.
Skin- KLK7 negative Merkel cell carcinoma.
Stomach- Gastric adenocarcinoma with moderate to strong KLK7 immunostaining of tumor cells.
Stomach- Gastric adenocarcinoma with moderate to strong KLK7 immunostaining of tumor cells.
Stomach- KLK7 negative gastrointestinal stromal tumor (GIST).
Stomach- KLK7 negative gastrointestinal stromal tumor (GIST).
Testis- KLK7 negative Leydig cell tumor.
Testis- KLK7 negative Leydig cell tumor.
Testis- KLK7 negative seminoma.
Testis- KLK7 negative seminoma.
Thyroid- KLK7 negative medullary carcinoma.
Thyroid- KLK7 negative medullary carcinoma.
Thyroid- KLK7 negative papillary carcinoma.
Thyroid- KLK7 negative papillary carcinoma.
Urinary bladder- KLK7 negative muscle-invasive urothelial carcinoma.
Urinary bladder- KLK7 negative muscle-invasive urothelial carcinoma.
Urinary bladder- Muscle-invasive urothelial carcinoma containing few interspersed tumor cells with strong KLK7 immunostaining.
Urinary bladder- Muscle-invasive urothelial carcinoma containing few interspersed tumor cells with strong KLK7 immunostaining.
Urinary bladder- Muscle-invasive urothelial carcinoma with strong KLK7 immunostaining of a fraction of tumor cells undergoing squamous differentiation.
Urinary bladder- Muscle-invasive urothelial carcinoma with strong KLK7 immunostaining of a fraction of tumor cells undergoing squamous differentiation.
Vulva- Squamous cell carcinoma showing a significant KLK7 immunostaining of tumor cells.
Vulva- Squamous cell carcinoma showing a significant KLK7 immunostaining of tumor cells.